We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $2.8B
1-Year Est. Return 13.35%
This Fund
S&P 500
This Quarter Est. Return
-9.15%
1 Year Est. Return
+13.35%
3 Year Est. Return
+27.45%
5 Year Est. Return
+53.33%
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
+$383M
Cap. Flow
+$97.2M
Cap. Flow %
5.59%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
3
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$117M
2
QXO
QXO Inc
QXO
+$23.7M

Top Sells

Rank Stock Value
1
LLYVK icon
Liberty Live Group Series C
LLYVK
+$43.6M
2
LSBPW
LakeShore Biopharma Warrants
LSBPW
+$19.6K

Sector Composition

Rank Sector Weight
1 Miscellaneous 68.78%
2 Industrials 30.87%
3 Healthcare 0.34%
4 Energy 0.01%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$804M 46.26%
1,207,500
+34,000
+3% +$21.8M
QXO
2
QXO Inc
QXO
$14B
$425M 24.44%
22,295,615
+1,142,747
+5% +$23.7M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$81B
$391M 22.5%
1,617,000
+1,032,000
+176% +$237M
RXO icon
4
RXO
RXO
$3.3B
$112M 6.43%
+7,266,839
New +$117M
SLDB icon
5
Solid Biosciences
SLDB
$1.12B
$5.93M 0.34%
961,251
– –
ANNA
6
AleAnna Inc
ANNA
$127M
$116K 0.01%
27,717
– –
ANNAW
7
AleAnna Inc Warrant
ANNAW
$9.74M
$112K 0.01%
490,000
– –
MNYWW
8
MoneyHero Ltd Warrants
MNYWW
$100K 0.01%
895,000
– –
CLDI icon
9
Calidi Biotherapeutics
CLDI
$3.49M
$1.58K ﹤0.01%
65
– –
LLYVK icon
10
Liberty Live Group Series C
LLYVK
$9.32B
– –
-537,051
Closed -$43.6M
LSBPW
11
DELISTED
LakeShore Biopharma Warrants
LSBPW
– –
-489,999
Closed -$19.6K

Similar funds

MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
PAI
Pittenger & Anderson Inc Lincoin, Nebraska $2.79B AUM 12.81% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
LIMS
Lasalle Investment Management Securities Baltimore, Maryland $2.81B AUM 16.57% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.79B AUM 18.53% 1-Year Est. Return
PCP
Proficio Capital Partners Newton, Massachusetts $2.79B AUM 27.93% 1-Year Est. Return

Finepoint Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Finepoint Capital held 11 positions worth $1.74B, up 28% from $1.36B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Finepoint Capital deployed $97.2M of net new capital in Q3 2025, opening 1 new position and adding to 3 existing holdings. Its largest new stake was RXO: 7,266,839 shares worth $112M.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 63% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the most notable exit was Liberty Live Group Series C, an estimated $43.6M sold.

  • Finepoint Capital's largest Q3 2025 buy was RXO: 7,266,839 shares worth $112M.
  • Finepoint Capital added most to QXO Inc in Q3 2025, an estimated $23.7M increase.
  • Finepoint Capital fully exited Liberty Live Group Series C in Q3 2025, selling an estimated $43.6M.
  • Finepoint Capital's ten largest holdings make up 100% of its $1.74B portfolio in Q3 2025.
  • Finepoint Capital opened 1 new position and closed 2 in Q3 2025.
  • Finepoint Capital's portfolio value rose 28% quarter-over-quarter to $1.74B.

Based on Finepoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.